date:Aug 05, 2014
ChromaDex Corp., an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced that it has entered into a material transfer agreement (MTA) with Murdoch Childrens Research Institute, the preeminent child health research institute in Australia.
ChromaDex will provide Murdoch Childrens Research Institute with quantities of its proprietary NIAGEN